Area of Interest:

Medicine

100%

Arrhythmias

62%

Catecholamine

90%

Heart

75%

Anesthesia

55%

Research Publications in Numbers

Books
0

Chapters
0

Articles
6

Abstracts
0

Selected Publications

Yamanaka, H., Y. Hayashi, M. Iwasaki, T. Kamibayashi, A. Yamatodani and T. Mashimo, 2010. Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine. Eur. J. Pharmacol., 647: 155-160.
CrossRef | PubMed | Direct Link |
Yamanaka, H., Y. Hayashi, Y. Watanabe, H. Uematu and T. Mashimo, 2009. Prolonged hoarseness and arytenoid cartilage dislocation after tracheal intubation. Br. J. Anaesth., 103: 452-455.
CrossRef | PubMed | Direct Link |
Iwasaki, M., Y. Hayashi, T. Kamibayashi, A. Ymatodani and T. Mashimo, 2008. The antiarrhythmic effect of centrally administered rilmenidine involves muscarinic receptors, protein kinase C and mitochondrial signalling pathways. Br. J. Pharmacol., 153: 1623-1630.
CrossRef | PubMed | Direct Link |
Matsuda, N., Y. Hayashi, Y. Takahashi and Y. Hattori, 2006. Phosphorylation of endothelial nitric-oxide synthase is diminished in mesenteric arteries from septic rabbits depending on the altered phosphatidylinositol 3-kinase/Akt pathway: Reversal effect of fluvastatin therapy. J. Pharmacol. Exp. Ther., 319: 1348-1354.
CrossRef | PubMed | Direct Link |
Kamei, M., S. Morita, Y. Hayashi, Y. Kanmura and M. Kuro, 2006. Carvedilol versus metoprolol for the prevention of atrial fibrillation after off-pump coronary bypass surgery: Rationale and design of the carvedilol or metoprolol post-revascularization atrial fibrillation controlled trial (COMPACT). Cardiovasc. Drugs Ther., 20: 219-227.
CrossRef | PubMed | Direct Link |
Ito, I., Y. Hayashi, Y. Kawai, M. Iwasaki and K. Takada et al., 2006. Diabetes mellitus reduces the antiarrhythmic effect of ion channel blockers. Anesth. Analg., 103: 545-550.
CrossRef | PubMed | Direct Link |